Effect of Different Concentrations of Jamun and Amla Extracts to Combat Diabetes Mellitus
Concentrations of Jamun and Amla Extracts to Combat Diabetes Mellitus
Keywords:syzygium cumini, Phyllanthus emblica, diabetes mellitus, fasting blood glucose
Diabetes mellitus (DM) is a metabolic disorder affecting the health of people at large scale. It adversely affects the quality of life and can be managed by changes in life style including diet Objective: To compare the effect of different concentrations of jamun and amla on blood Glycemic Index of diabetes mellitus. Methods: A total 25 male Wister rats aged 10-12 weeks, weight above 150g were selected for the 2 months study. Male rats were purchased from IMBB research laboratory, The University of Lahore (UOL). During the efficacy study, streptozotocin (STZ) induced rats were divided into five homogenous groups with 5 rats in each group. To For control group and T1, T2, T3 and T4 includes normal diet with different concentration of Jamun and Amla extracts. The change in body weight (g) and fasting blood glucose (FBG)(mg/dL) for each group of rats were monitored on every 15 days to estimate any suppressing effect of seed formulation. Results: The mean age of diabetic rats selected for study were10.61±0.493 weeks. Weight of STZ induced rats were monitored but no significant difference was shown, however mean weight of 5% Amla and 5% Jamun supplemented diet groups show an increase in mean body weight pre- and post-treatment 18.8±15.95g and 8±19.85g respectively. The minimum post-treatment FBG level of rats was noted in 5% jamun and 5% amla supplemented group with mean FBG 111.4±24mg/dL and 131.2±57.1mg/dL respectively. Conclusions: The study concluded that jamun and amla both groups show a significant reduction in fasting blood glucose level but no significant mean difference was shown in body weight gain. At the end of the study 5% amla and 5% jamun composition groups had shown significant improvement in FBG levels among diabetic induced rats.
Lu DY, Che JY, Yarla NS, Zhu H, Lu TR, Xu B, et al. Type 2 diabetes study, introduction and perspective. The Open Diabetes Journal.2018; 8(1):13-21.doi: 10.2174/1876524601808010013.
American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020Jan;43(Suppl 1): S14-S31. doi: 10.2337/dc20-S002.
Basit A, Fawwad A, Qureshi H, Shera A. Prevalence of diabetes, prediabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP),2016–2017.BMJ Open.2018;8(8): e020961.doi: 10.1136/bmjopen-2017-020961.
Blas E, Kurup AS, editors. Equity, social determinants and public health programmes. World Health Organization; 2010.s. 159-176.ISBN: 9789241563970. Availabl3 at: https://apps.who.int/iris/handle/10665/44289.
Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice. 2018 Apr; 138:271-81. doi: 10.1016/j.diabres.2018.02.023.
Linnenkamp U. Guariguata L. Beagley J. Whiting D.R. Cho N.H. The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy. Diabetes research and clinical practice. 2014 Feb;103(2):186-96. doi: 10.1016/j.diabres.2013.11.004.
Basit A, Fawwad A, Baqa K. Pakistan and diabetes—a country on the edge. Diabetes research and clinical practice. 2018Jan; 147:166–8.doi: 10.1016/j.diabres.2018.11.001.
Costa WJ, Penha-Silva N, Bezerra IM, Paulo dos Santos I, Ramos JL, Castro JM, Pereira JE, Silva AP, Monteiro A, de Abreu LC. Analysis of Diabetes Mellitus-Related Amputations in the State of Espírito Santo, Brazil. Medicina. 2020 Jun;56(6):287.doi: 10.7326/M16-0273.
Ahmed R, Tariq M, Hussain M, Andleeb A, Masoud MS, Ali I, Mraiche F, Hasan A. Phenolic contents-based assessment of therapeutic potential of Syzygium cumini leaves extract. PloS one. 2019 Aug;14(8): e0221318.doi: 10.1371/journal.pone.0221318.
Parveen S, Khan AA, Khan QA. Antihyperlipidemic effect of seeds of jamun (eugenia jambolana) in subjects of intermediate hyperglycemia: a pilot study. Traditional and Integrative Medicine. 2020; 5(4):191-197.doi: 10.18502/tim.v5i4.5164
Chagas VT, França LM, Malik S, Paes AM. Syzygium cumini (L.) skeels: a prominent source of bioactive molecules against cardiometabolic diseases. Frontiers in pharmacology. 2015 Nov; 6:259.doi: 10.3389/fphar.2015.00259.
Chhikara N, Kaur R, Jaglan S, Sharma P, Gat Y, Panghal A. Bioactive compounds and pharmacological and food applications of Syzygium cumini–a review. Food & function. 2018;9(12):6096-115.doi: 10.1039/c8fo00654g.
Raza A, Saif-ul-Malook NS, Qasrani SA, Sharif MN, Akram MN, Ali MU. Extraction of bioactive components from the fruit and seed of jamun (Syzygium cumini) through conventional solvent extraction method. American-Eurasian Journal of Agricultural and Environmental Sciences. 2015;15(6):991-6.doi: 10.5829/idosi.aejaes.2015.15.6.12670
Husain I, Zameer S, Madaan T, Minhaj A, Ahmad W, Iqubaal A, Ali A, Najmi AK. Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review. Metabolic brain disease. 2019 Aug;34(4):957-65.doi: 10.1007/s11011-019-00400-9.
Variya BC, Bakrania AK, Patel SS. Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms. Pharmacological research. 2016 Sep;111:180-200.doi: 10.1016/j.phrs.2016.06.013.
Yang B, Liu P. Composition and biological activities of hydrolyzable tannins of fruits of Phyllanthus emblica. Journal of agricultural and food chemistry. 2014 Jan;62(3):529-41.doi: 10.1021/jf404703k.
Krishnaveni M, Mirunalini S, Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder, Journal of Basic and Clinical Physiology and Pharmacology,2010;21(1):93-105.doi: 10.1515/jbcpp.2010.21.1.93.
Pientaweeratch S, Panapisal V, Tansirikongkol A. Antioxidant, anti-collagenase and anti-elastase activities of Phyllanthus emblica, Manilkara zapota and silymarin: An in vitro comparative study for anti-aging applications. Pharmaceutical biology. 2016 Sep 1;54(9):1865-72.doi: 10.3109/13880209.2015.1133658.
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. The Journal of Clinical Endocrinology & Metabolism. 2000 Jul;85(7):2402-10. doi: 10.1210/jcem.85.7.6661.
Ahn J, Choi W, Kim S, Ha T. Anti-diabetic effect of watermelon (Citrullus vulgaris Schrad) on Streptozotocin-induced diabetic mice. Food science and biotechnology. 2011; 20(1):251-4.doi: 10.1007/s10068-011-0034-5.
Neha A, Vijaya N, Khan TN. Effect of jamun (Syzygium cumini L.) seed powder supplementation on blood glucose level of type-II diabetic subject. Food science research journal. 2015;6(2):353-6.doi: 10.15740/HAS/FSRJ/6.2/353-356
Elobeid MA, Ahmed EA. Antidiabetic efficacy of aqueous fruit extract of Amla (Emblica officinalis, Gaertn) in streptozotocin-induced diabetes mellitus in male rats. Tropical Journal of Pharmaceutical Research. 2015 Oct 1;14(5):801-6.doi: 10.4314/tjpr.v14i5.9.
Mahajan S, Chauhan P, Mishra M, Yadav D, Debnath M, Prasad GB. Antidiabetic potential of eugenia jambolana ethanolic seed extract: Effect on antihyperlipidemic and antioxidant in experimental streptozotocin-induced diabetic rats. Adv Complement Alt Med. 2018; 2:1-9.doi: 10.31031/ACAM.2018.02.000540.
How to Cite
Copyright (c) 2022 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments email@example.com